Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Pamela M. Moye-Dickerson"'
Publikováno v:
Journal of Pharmacy Practice. 34:319-324
Background: Efavirenz (Sustiva®) is used for the treatment of human immunodeficiency virus (HIV) type 1 infection. Hepatoxicity is a known potential adverse drug event with efavirenz; however, to our knowledge, vanishing bile duct syndrome (VBDS), a
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4c5e5130b84eb8de6b448228e46f1c58
https://doi.org/10.1177/0897190019868358
https://doi.org/10.1177/0897190019868358
Autor:
Pamela M. Moye-Dickerson, Maria Miller Thurston, Teresa Pounds, Tze-chun Vivian Liao, Tanna Lim
Publikováno v:
JACCP: JOURNAL OF THE AMERICAN COLLEGE OF CLINICAL PHARMACY. 2:281-287
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::624578b74f0f4514d62411cb3f96603c
https://doi.org/10.1002/jac5.1072
https://doi.org/10.1002/jac5.1072
Publikováno v:
JACCP: JOURNAL OF THE AMERICAN COLLEGE OF CLINICAL PHARMACY. 2:188-188
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::efe0ff2359ba43fff6e077062393cac9
https://doi.org/10.1002/jac5.1075
https://doi.org/10.1002/jac5.1075
Publikováno v:
American Journal of Men's Health
American Journal of Men's Health, Vol 13 (2019)
American Journal of Men's Health, Vol 13 (2019)
Heart failure (HF) is responsible for more 30-day readmissions than any other condition. Minorities, particularly African American males (AAM), are at much higher risk for readmission than the general population. In this study, demographic, social, a
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ddb58884cd2e686c2e34215060183ed0
https://doi.org/10.1177/1557988318814295
https://doi.org/10.1177/1557988318814295